Discover 1,107 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,107
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Bridgeport CT, The Bronx NY, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase3, Recruiting
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Primary Myelofibrosis, Post-PV MF,
Location: Canton OH, Cincinnati OH, Birmingham AL, Houston TX
Sponsor: Telios Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05280509
Phase1, Phase2, Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: New York NY, Rochester NY, Hollywood FL, Atlanta GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase2, Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Scarborough ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
for
Pancreatic Cancer
Location: Lake Success NY, Millburn NJ, Montreal, Baltimore MD,
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT02674100
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Location: St. John's, Moncton, Boston MA, Bristol CT, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, Worcester MA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
Comparison of Healing Measures Tibial Fractures Following Standard Intramedullary Nailing or Micromotion Tibial Intramedullary Nailing
for
Tibial Fractures
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT06679049
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)